Retirement

Other

Total

Salary

funding

benefits

2020

2019(1)

2018(1)

R’000

Executive Directors

17 935

1 848

3 161

22 944

46 948

66 808

(1) Total remuneration for the financial year excludes gains derived from the long-term incentive schemes which are separately disclosed.

Gains on Long-term incentives and Share Appreciation Rights for the Executive Directors’ and former Executive Director were as follows:

		Long-term incentive rights vested(1) R’000		Share appreciation rights, with and without CPTs exercised R’000		Total 2020 R’000		Total 2019 R’000		Total 2018 R’000
Executive Directors		2 657		—		2 657		25 025		20 515

(1) Long-term incentives for the 2020 financial year represent incentives approved on the group results for the 2020 financial year, payable in the 2021 financial year.

Remuneration and benefits paid and short-term incentives approved for the Prescribed Officers were as follows:

	Salary R’000	Retirement funding R’000	Other benefits R’000	Total 2020 R’000	Total 2019(1) R’000	Total 2018(1) R’000
Prescribed Officers	38 272	6 554	7 316	52 142	67 488	89 007
Number of Prescribed Officers				6	8	8

(1) Total remuneration for the financial year excludes gains derived from the long-term incentive schemes which are separately disclosed.

Gains on Long-term incentives and Share Appreciation Rights for the Prescribed Officers were as follows:

		Long-term incentive rights vested(1) R’000		Share appreciation rights, with and without CPTs exercised R’000		Total 2020 R’000		Total 2019 R’000		Total 2018 R’000
Prescribed Officers		4 201		—		4 201		68 559		44 962

(1) Long-term incentives for the 2020 financial year represent incentives approved on the group results for the 2020 financial year, payable in the 2021 financial year.

Messrs. Cornell and Nqwababa agreed with the Board to terminate their employment. The Board has acknowledged, following an external investigation, that there was no personal wrongdoing on their part. The remuneration and benefits earned during their tenure as Joint CEOs and Presidents in addition to the mutual separation detail was as follows:

		Salary R’000		Retirement funding R’000		Other benefits R’000		Total 2020 R’000
Former Joint CEOs and Presidents		29 278		11 682		51 184		92 144

(1) Total remuneration for the financial year excludes gains derived from the long-term incentive schemes which are separately disclosed.

Gains on Long-term incentives and Share Appreciation Rights for the former Joint CEOs and Presidents were as follows:

		Long term incentive rights vested(1) R’000		Share appreciation rights, with and without CPTs exercised R’000		Total 2020 R’000
Former Joint CEOs and Presidents		3 765		—		3 765

(1) Long-term incentives for the 2020 financial year represent incentives approved on the group results for the 2020 financial year, payable in the 2021 financial year.

The gains from SARs exercised during 2020 is disclosed in the audited Remuneration Report.

The total IFRS 2 charge for Executive Directors and the Prescribed Officers in 2020 amounted to R10 million and R16 million, respectively and amounted to R14 million for the former Joint CEOs and Presidents.

Non-executive Directors’ emoluments for the year was as follows:

		Board meeting fees R’000		Lead Director fees R’000		Committee fees R’000		Ad Hoc Special Board — Committee Meeting R’000		Other R’000		Total 2020 R’000		Total 2019 R’000		Total 2018 R’000
Non-executive Directors		29 952		637		7 959		1 172		23		39 743		32 455		27 823